Scientific article
In-hospital initiation of PCSK9 inhibitors in ACS : pros and cons
ContributorsKrychtiuk, Konstantin A; Claeys, Marc J; Gencer, Baris; Mach, François
Published inEuroIntervention, vol. 19, no. 4, p. e283-e285
Publication date2023-07-17
First online date2023-07-17
Keywords
- Humans
- PCSK9 Inhibitors
- Proprotein Convertase 9
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Cognition
Affiliation entities
Research groups
Citation (ISO format)
KRYCHTIUK, Konstantin A et al. In-hospital initiation of PCSK9 inhibitors in ACS : pros and cons. In: EuroIntervention, 2023, vol. 19, n° 4, p. e283–e285. doi: 10.4244/EIJ-E-23-00014
Main files (1)
Article (Published version)
Identifiers
- PID : unige:178950
- DOI : 10.4244/EIJ-E-23-00014
- PMID : 37458121
- PMCID : PMC10333913
Additional URL for this publicationhttps://eurointervention.pcronline.com/article/in-hospital-initiation-of-pcsk9-inhibitors-in-acs-pros-and-cons
Journal ISSN1774-024X
